Nutrient intake and serum level of gamma-glutamyltransferase, MCP-1 and homocysteine in early stages of heart failure

Clinical Nutrition

Volumn 30, Issue 1, 2011, Pages 73-78

  Makarewicz Wujec, Magdalena ^a   Kozlowska Wojciechowska, Malgorzata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; HOMOCYSTEINE; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CHOLESTEROL INTAKE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIETARY FIBER; FAT INTAKE; FEMALE; FOOD INTAKE; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE;

CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHOLESTEROL, DIETARY; ENERGY INTAKE; FEMALE; FOLIC ACID; GAMMA-GLUTAMYLTRANSFERASE; HEART FAILURE; HEMATINICS; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES;

EID: 79451473785     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2010.07.008     Document Type: Article

References (46)

1. McMurray J.J., Pfeffer M.A. Heart failure. Lancet 2005, 365:1877-1889.
2. Lee D.S., Mamdani M.M., Austin P.C., Gong Y., Liu P.P., Rouleau J.L., et al. Trends in heart failure outcomes and pharmacotherapy: 1992-2000. Am J Med 2004, 116:581-589.
3. Stewart S., Jenkins A., Buchan S., McGuire A., Capewell S., McMurray J.J. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002, 4:361-371.
4. Lemon S.C., Olendzki B., Magner R., Li W., Culver A.L., Ockene I., et al. The dietary quality of persons with heart failure in NHANES 1999-2006. J Gen Intern Med 2009, 25(2):135-140. published online October 31. doi:10.1007/s11606-009-1139-x.
5. Keith M.E., Walsh N.A., Darling P.B., Hanninen S.A., Thirugnanam S., Leong-Poi H., et al. B-vitamin deficiency in hospitalized patients with heart failure. J Am Diet Assoc 2009, 109:1406-1410.
6. Jaques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001, 73:613-621.
7. Koehler K.M., Baumgartner R.N., Garry P.J., Allen R.H., Stabler S.P., Rimm E.B. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr 2001, 73:628-637.
8. Vasan R.S., Beiser A., D'Agostino R.B., Levy D., Selhub J., Jacques P.F., et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003, 289:1257.
9. Naruszewicz M., Jankowska E.A., Zymlinski R., Bukowska H., Millo B., Banasiak W., et al. Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance-pilot study. Atherosclerosis 2007, 194:408-414.
10. Wang G., Karmin O. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals. Biochem J 2001, 357:233-240.
11. de Lemos J.A., Morrow D.A., Blazing M.A., Jarolim P., Wiviott S.D., Sabatine M.S., et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 2007, 50:2117-2124.
12. Kavsak P.A., Ko D.T., Newman A.M., Palomaki G.E., Lustig V., MacRae A.R., et al. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 2007, 53:2112-2118.
13. Lee D.H., Blomhoff R., Jacobs D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Rad Res 2004, 38:535-539.
14. Dominici S., Paolicchi A., Corti A., Maellaro E., Pompella A. Prooxidant reactions promoted by soluble and cell-bound gammaglutamyltransferase activity. Methods Enzymol 2005, 401:484-501.
15. Dominici S., Paolicchi A., Lorenzini E., Maellaro E., Comporti M., Pieri L., et al. Gammaglutamyltransferase- dependent prooxidant reactions: a factor in multiple processes. Biofactors 2003, 17:187-198.
16. Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., Ulmer H. Gamma-Glutamyltransferase as a risk factor for cardiovascular disease mortality an epidemiological Investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112:2130-2137.
17. Duk-Hee L., Silventoinen K., Hu G. Serum gamma-glutamyltransferase predicts non-fatalmyocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women. Eur Heart J 2006, 27:2170-2176.
18. Garlick P.J. Toxicity of methionine in humans. J Nutr 2006, 136:1722S-1725S.
19. Appel L.J., Miller E.R., Jee S.H., Stolzenberg-Solomon R., Lin P.H., Erlinger T., et al. Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 2000, 102:852-857.
20. Morrison H.I., Schaubel D., Desmeules M., Wigle D.T. Serum folate and risk of fatal coronary heart disease. JAMA 1996, 275:1893-1896.
21. Emdin M., Passino C., Michelassi C., Donato L., Pompella A., Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int J Cardiol 2009, 136:80-85.
22. De Lemos J.A., Morrow D.A., Sabatine M.S., Murphy S.A., Gibson C.M., Antman E.M., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003, 107:690-695.
23. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., et al. Hormonal changes and catabolic/anabolik imbalance in chronic heart failure and their importance for cardiac caxecia. Circuation 1997, 96:526-534.
24. Levitan E.B., Wolk A., Mittleman M.A. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 2009, 169:851-857.
25. Heo S., Lennie T.A., Moser D.K., Okoli C. Heart failure patients' perceptions on nutrition and dietary adherence. Eur J Cardiovasc Nurs 2009, 8(5):323-328. published online Jul 7. doi:10.1016/j.ejcnurse.2009.05.005.
26. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Franch H.A., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114(1):82-96. American Heart Association Nutrition Committee.
27. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth joint task force of the European Society of Cardiology and other Societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2007, 28:2375-2414.
28. Grover S.A., Kaouache M., Joseph L., Barter P., Davignon J. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Arch Intern Med 2009, 169:1775-1780.
29. Freitas H.F., Barbosa E.A., Rosa F.H., Lima A.C., Mansur A.J. Association of HDL cholesterol and triglycerides with mortality in patients with heart failure. Braz J Med Biol Res 2009, 42:420-425.
30. May H.T., Alharethi R., Anderson J.L., Muhlestein J.B., Reyna S.P., Bair T.L., et al. Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease. Cardiology 2007, 107:178-184.
31. Andria G., Scala I., Sebastio G. Health implications of homocysteine and folates: possible preventive measures. Nutr Metab Cardiovasc Dis 2005, 15:87-93.
32. Doshi S.N., McDowell I.F., Moat S.J., Payne N., Durrant H.J., Lewis M.J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002, 105:22-26.
33. Verhaar M.C., Wever R.M.F., Kastelein J.J.P., Van Dam T., Koomans H.A., Reblink T.J. 5-methyltetrahydrofolate, the active form of folic acid, improves endothelial function in familial hypercholesterolemia. Circulation 1998, 97:237-241.
34. Durand P., Prost M., Blache D. Prothrombotic effects of folic acid deficient diet in rats platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996, 121:231-243.
35. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006, 354:1567-1577.
36. Wannamethee S.G., Lennon L., Shaper A.G. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008, 201:168-175.
37. Demircan S., Yazici M., Durna K., Kilicaslan F., Demir S., Pinar M., et al. The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009, 32:220-225.
38. Franzini M., Corti A., Martinelli B., Del Corso A., Emdin M. gamma-Glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009, 202:119-127.
39. Fraser A., Harris R., Sattar N., Ebrahim S., Smith G.D., Lawlor D.A. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007, 27:2729-2735.
40. Lee D.H., Steffen L.M., Jacobs D.R. Association between serum gamma-glutamyltransferase and dietary factors: the coronary artery risk development in young adults (CARDIA) study. Am J Clin Nutr 2004, 79:600-605.
41. Shin J.Y., Chang S.J., Shin Y.G., Seo K.S., Chung C.H. Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diabetes Res Clin Pract 2009, 84:152-157.
42. Nettleton J.A., Steffen L.M., Loehr L.R., Rosamond W.D., Folsom A.R. Incident heart failure is associated with lower whole-grain intake and greater high-fat dairy and egg intake in the atherosclerosis risk in communities (ARIC) study. J Am Diet Assoc 2008, 108:1881-1887.
43. Elvevoll E.O., Eilertsen K.E., Brox J., Dragnes B.T., Falkenberg P., Olsen J.O., et al. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 2008, 200:396-402.
44. Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Bibus D.M., et al. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43:65-77.
45. Berrahmoune H., Lamont J.V., Herbeth B., Fitzgerald P.S., Visvikis-Siest S. Biological determinants of reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem 2006, 52:504-510.
46. Desai A., Lankford H., Warren J. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 2001, 25:179-186.